Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Love Pharma Inc. (CSE:LUV)

N/A UNCHANGED
Last Price Updated: 1:45 PM EDT, May 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Love Pharma Inc.

News headline image
Jolt Health To Acquire HCQ Transdermal Patch Technology
Via ACCESSWIRE
News headline image
Love Pharma Inc. Announces Share Consolidation
Via ACCESSWIRE
News headline image
Love Pharma Sells Microdoz, Increases Focus on Biotechnology
Via ACCESSWIRE
News headline image
Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid
From Love Pharma Inc.
Via GlobeNewswire
News headline image
Love Pharma Investee, Starton Therapeutics, Strengthens Board With New Member (Re-release)
Via ACCESSWIRE
News headline image
Naltrexone Demonstrates Promising Long COVID Application
Via ACCESSWIRE
News headline image
Love Pharma Closes Acquisition of Doc Hygiene
Via ACCESSWIRE
News headline image
Love Pharma - Johns Hopkins University Psilocybin Trial Advances Toward Launch in 2022
Via ACCESSWIRE
News headline image
Love Pharma Signs Letter of Intent To Acquire Naltrexone Therapeutics Inc.
Via ACCESSWIRE
News headline image
Love Pharma Subsidiary Doc Hygiene Delivers Sanitizer Products To Support Community Needs With Operation "Clean Hands" and Closes Final Tranche of Financing
Via ACCESSWIRE
News headline image
Love Pharma Launches Proprietary E-Commerce Platform for Online Sales
Via ACCESSWIRE
News headline image
Love Pharma Initiates First Steps Towards a Strategic Alliance with Starton Therapeutics with Investment in this Biotech Leader
Via ACCESSWIRE
News headline image
Love Pharma Delivers Letter to Shareholders
Via ACCESSWIRE
News headline image
Love Pharma Inc. Announces First Closing of Financing
Via ACCESSWIRE
News headline image
Love Pharma Announces Strategic Acquisition of Doc Hygiene Pharmaceuticals Inc.
Via ACCESSWIRE
News headline image
Love Pharma Inc. Announces Second Closing of Financing
VANCOUVER, BC / ACCESSWIRE / June 29, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a second closing of its previously announced non-brokered... 
From Love Pharma Inc.
Via AccessWire
News headline image
Love Pharma Inc. Announces Closing of Financing
VANCOUVER, BC / ACCESSWIRE / May 6, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed the second tranche of a non-brokered private placement. The... 
From Love Pharma Inc.
Via AccessWire
News headline image
Love Pharma Inc. Announces First Closing of Financing
VANCOUVER, BC / ACCESSWIRE / April 5, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a first closing of a non-brokered private placement. The... 
From Love Pharma Inc.
Via AccessWire
News headline image
Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research
VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company is pleased to announce updated details on the proposed Microdoz Therapy... 
From Love Pharma Inc.
Via AccessWire
Topics Cannabis Intellectual Property
News headline image
Love Pharma Signs Letter of Intent to Acquire 100% Interest in MicrDoz Therapy Inc. To Expedite Pilot Study of Psilocybin Assisted Treatment of Cannabis Use Disorder with World Leading University
VANCOUVER, BC / ACCESSWIRE / November 23, 2021 / LOVE Pharma Inc. ("LOVE" and or the "Company") (CSE:LUV) (FSE:G1Q0), is pleased to announce that it has executed a Letter of Intent ("LOI") to acquire... 
From Love Pharma Inc.
Via AccessWire
Topics Cannabis Intellectual Property
News headline image
LOVE Pharma Announces Advanced Psilocybin Delivery System
Emerging Sexual Health and Wellness Company Announces Development of Muco-Adhesive Strip Technology for the Delivery of Psilocybin VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / LOVE Pharma Co.... 
From Love Pharma Inc.
Via AccessWire
News headline image
Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange
VANCOUVER, BC / ACCESSWIRE / October 12, 2021 / Love Pharma Inc. (CSE:LUV)(FSE:G1Q0) (the "Company") a specialized health and wellness company, is pleased to announce that its common shares were... 
From Love Pharma Inc.
Via AccessWire
News headline image
LOVE Pharma Names Joshua Maurice Chief Operating Officer
Longtime Marketing, Development, and Sales Executive to Head Day-to-Day Operations for Emerging Sexual Health, Wellness, and Psychedelics Brand VANCOUVER, BC / ACCESSWIRE / October 6, 2021 / LOVE... 
From Love Pharma Inc.
Via AccessWire
Topics Intellectual Property
News headline image
Love Pharma, Inc., Formerly Glenbriar Technologies, Inc., Announces Name Change, Consolidation, and Acquisition of Kick Pharmaceuticals, Inc
VANCOUVER, BC / ACCESSWIRE / September 30, 2021 / Love Pharma Inc. (CSE:LUV) (the "Company") announces that it has changed its name, has completed the arms-length acquisition of all of the shares of... 
From Love Pharma Inc.
Via AccessWire
Topics Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.